[go: up one dir, main page]

MA24777A1 - Compose et son utilisation - Google Patents

Compose et son utilisation

Info

Publication number
MA24777A1
MA24777A1 MA25489A MA25489A MA24777A1 MA 24777 A1 MA24777 A1 MA 24777A1 MA 25489 A MA25489 A MA 25489A MA 25489 A MA25489 A MA 25489A MA 24777 A1 MA24777 A1 MA 24777A1
Authority
MA
Morocco
Prior art keywords
compound
Prior art date
Application number
MA25489A
Other languages
English (en)
Inventor
Arthur Griffith-Skinner Nigel
Anthony Hill Derek
William Packham Terence
Mary Edmeades Lorraine
Thronton Hill Graham
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10833464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA24777(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MA24777A1 publication Critical patent/MA24777A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA25489A 1998-06-10 1999-03-10 Compose et son utilisation MA24777A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812413.4A GB9812413D0 (en) 1998-06-10 1998-06-10 Compound and its use

Publications (1)

Publication Number Publication Date
MA24777A1 true MA24777A1 (fr) 1999-10-01

Family

ID=10833464

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25489A MA24777A1 (fr) 1998-06-10 1999-03-10 Compose et son utilisation

Country Status (31)

Country Link
US (1) US6333198B1 (fr)
EP (2) EP1170588A1 (fr)
JP (1) JP2989189B1 (fr)
KR (1) KR100322354B1 (fr)
CN (2) CN1238454A (fr)
AP (3) AP0102286A0 (fr)
AR (1) AR014074A1 (fr)
AT (1) ATE218552T1 (fr)
AU (1) AU2031999A (fr)
BR (1) BR9900984A (fr)
CA (1) CA2265194C (fr)
DE (1) DE69901656T2 (fr)
DK (1) DK0963980T3 (fr)
EA (1) EA000666B1 (fr)
ES (1) ES2178342T3 (fr)
GB (1) GB9812413D0 (fr)
HR (1) HRP990074A2 (fr)
HU (1) HUP9900592A3 (fr)
ID (1) ID22957A (fr)
MA (1) MA24777A1 (fr)
NO (2) NO991151L (fr)
NZ (1) NZ334590A (fr)
PE (1) PE20000332A1 (fr)
PL (1) PL331870A1 (fr)
PT (1) PT963980E (fr)
SG (1) SG85628A1 (fr)
SI (1) SI0963980T1 (fr)
TR (1) TR199900520A3 (fr)
UY (1) UY25946A1 (fr)
YU (1) YU12399A (fr)
ZA (1) ZA991951B (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055177A1 (en) * 1999-03-10 2002-05-09 Glaxo Wellcome Inc. Compound and its use
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
EP1309557B9 (fr) 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
SI1309555T1 (sl) 2000-12-29 2005-12-31 Pfizer Ltd Postopek izdelave amlodipin-maleata
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309556B1 (fr) 2000-12-29 2004-11-24 Pfizer Limited Fumarate d'amlodipine
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
MXPA03005886A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
EP1346214A2 (fr) 2000-12-29 2003-09-24 Pfizer Limited Standards de reference destines a la determination de la purete ou de la stabilite de maleate d'amlodipine et procedes correspondants
EP1309554A1 (fr) 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Derive d'amide d'amlodipine
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
DE10134980C2 (de) * 2001-07-17 2003-05-28 Helm Ag Verfahren zur Herstellung von Lamotrigin
CA2366521C (fr) 2001-12-24 2007-03-06 Brantford Chemicals Inc. Un procede nouveau et efficace de preparation de lamotrigine et d'autres 3,5-diamino-1,2,4-triazines substituees en position 6
AU2003235435A1 (en) * 2002-03-20 2003-10-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of quetiapine hemifumarate
HU225667B1 (en) * 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
ES2209639B1 (es) 2002-10-31 2005-08-01 Vita Cientifica, S.L. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
GB2395483A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Crystalline lamotrigine and its monohydrate
CA2657076A1 (fr) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Procede de preparation de sels calciques de rosuvastatine
EP1601658A1 (fr) * 2003-11-24 2005-12-07 Teva Pharmaceutical Industries Limited Sels d'ammonium cristallins de la rosuvastatine
ES2364143T3 (es) * 2003-12-02 2011-08-25 Teva Pharmaceutical Industries Ltd. Estandar de referencia para caracterización de rosuvastatina.
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
MXPA06008584A (es) * 2004-01-30 2007-04-16 Teva Pharma Polimorfos de acido libre de montelukast.
EP1709002A2 (fr) * 2004-01-30 2006-10-11 Teva Pharmaceutical Industries Ltd. Montelukast de sodium polymorphe
MD2823G2 (ro) * 2004-02-12 2006-05-31 Институт Химии Академии Наук Молдовы Procedeu de determinare cantitativă a sclareolului în extractele, obţinute din salvia de muscat
ES2327762T3 (es) * 2004-04-21 2009-11-03 Teva Pharmaceutical Industries Ltd Procedimiento para preparar montelukast sodico.
TW200613294A (en) * 2004-04-26 2006-05-01 Teva Gyogyszergyar Reszvenytarsasag Process for preparation of mycophenolic acid and ester derivatives thereof
MXPA06005658A (es) * 2004-04-27 2007-04-10 Teva Gyogyszergyar Zartkoruen Proceso para preparacion de micofenolato mofetil, y otros esteres de acido micofenolico.
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
CA2561386A1 (fr) * 2004-06-28 2006-01-12 Teva Pharmaceutical Fine Chemicals S.R.L. Mandelate d'atomoxetine et de tomoxetine enantiomeriquement purs
JP2007508379A (ja) * 2004-07-13 2007-04-05 テバ ファーマシューティカル インダストリーズ リミティド Ｔｅｍｐｏ媒介型酸化段階を包含するロスバスタチンの調製方法
EP1699773A2 (fr) * 2004-07-20 2006-09-13 Ceva Gyogyszergyar R Szv Nytarsasag Procede pour la preparation de mycophenolate sodique cristalline
CA2568629A1 (fr) * 2004-07-22 2006-02-23 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphes du chlorhydrate d'atomoxetine
WO2006029253A2 (fr) * 2004-09-04 2006-03-16 Teva Pharmaceutical Industries Ltd. Impurete de valacyclovir isolee, son procede de preparation et son utilisation comme standard de reference
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
ES2263407T1 (es) * 2004-09-28 2006-12-16 Teva Pharmaceutical Industries Ltd Procedimiento para la preparacion de formas de atorvastatina calcica sustancialmente libres de impurezas.
JP2007514777A (ja) * 2004-10-19 2007-06-07 テバ ファーマシューティカル インダストリーズ リミティド テガセロッドマレエートの精製
US7678551B2 (en) * 2004-10-25 2010-03-16 Seradyn, Inc. Immunoassays for lamotrigine
US20060194869A1 (en) * 2004-12-23 2006-08-31 Santiago Ini Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
US7462743B2 (en) * 2005-01-11 2008-12-09 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of memantine hydrochloride
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
CA2680693A1 (fr) * 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Elaboration de la rosuvastatine
EP1866295A2 (fr) * 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Procedes de preparation d'intermediaire linezolid
CA2599475A1 (fr) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Hydrochlorure de duloxetine pur
JP2008501721A (ja) * 2005-04-05 2008-01-24 テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
US7417165B2 (en) * 2005-04-06 2008-08-26 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
US20070066846A1 (en) * 2005-04-11 2007-03-22 Asher Maymon Process for making (S)-Pregabalin
US7687622B2 (en) * 2005-04-14 2010-03-30 Teva Pharmaceutical Industries, Ltd Process for preparing quetiapine fumarate
US20080280977A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
US7763749B2 (en) * 2005-05-10 2010-07-27 Teva Pharmaceutical Industries Ltd. Method for the preparation of Pregabalin and salts thereof
KR20070067077A (ko) * 2005-05-10 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이소부틸글루타르산을 함유하지 않는 프레가발린 및 이의제조 방법
WO2006121557A1 (fr) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabaline exempte de lactame et son procede de preparation
US20070043241A1 (en) * 2005-05-10 2007-02-22 Lilach Hedvati Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid
ES2334260T3 (es) 2005-05-23 2010-03-08 Teva Pharmaceutical Industries Ltd. Procedimientos para la preparacion de la forma i cristalina de clorhidrato de cinacalcet.
CA2606945A1 (fr) * 2005-06-27 2007-01-04 Sicor, Inc. Impurete d'un intermediaire de l'anastrozole, et ses applications
BRPI0611116A2 (pt) * 2005-06-27 2010-08-10 Sicor Inc uma impureza de intermediário de anastrozol e seus usos
EP1904448B1 (fr) * 2005-07-05 2011-02-02 Teva Pharmaceutical Industries, Ltd. Purification du montélukast
JP2008515931A (ja) * 2005-08-16 2008-05-15 テバ ファーマシューティカル インダストリーズ リミティド 結晶形ロスバスタチン中間体
WO2007035789A1 (fr) * 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Acides 3-carbamoylméthyl-5-méthylhexanoïques chiraux, intermédiaires clés pour la nouvelle synthèse de la (s)-prégabaline
US20070197529A1 (en) * 2005-12-01 2007-08-23 Viviana Braude Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
EP1863782A1 (fr) * 2005-12-05 2007-12-12 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol)thiophene, une impurete du duloxetine chlorhydrate
WO2007069264A2 (fr) * 2005-12-15 2007-06-21 Alembic Limited Nouveaux composes
CA2630478A1 (fr) * 2005-12-27 2007-07-05 Teva Pharmaceutical Industries, Ltd Procedes de preparation de bromhydrate de darifenacine
BRPI0702852A2 (pt) * 2006-03-27 2012-08-07 Teva Pharmaceutical Ind Ltda processos para preparaÇço de Ácido hidroclorÍdrico de memantine substancialmente livre de impurezas, para determinar o grau de pureza do mesmo e para fabricaÇço de produto famacÊutico derivado; seus compostos e componentes
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
GB0609835D0 (en) * 2006-05-18 2006-06-28 Pliva Istrazivanje I Razvoj D Impurities of a pharmaceutical product
WO2007139933A2 (fr) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
CA2649117A1 (fr) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Utilisation de la resolution enzymatique pour la preparation d'intermediaires de pregabaline
US20080015385A1 (en) * 2006-05-31 2008-01-17 Lilach Hedvati Preparation of (S)-pregabalin-nitrile
EP2032712B1 (fr) * 2006-06-29 2010-02-10 Ivax Pharmaceuticals S.R.O. Régulation de la production de métabolites acides
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
WO2008019798A1 (fr) * 2006-08-14 2008-02-21 Lonza Ag Procédé de préparation de lamotrigine
US20080242877A1 (en) * 2007-02-26 2008-10-02 Vinod Kumar Kansal Intermediates and processes for the synthesis of Ramelteon
BRPI0803092A2 (pt) * 2007-03-22 2011-08-30 Teva Pharma sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina
US20080254520A1 (en) * 2007-04-11 2008-10-16 Eva Gulyas Method for reducing impurity level in mycophenolic acid fermentation
EP2098519A1 (fr) * 2007-05-31 2009-09-09 Teva Pharmaceutical Industries Ltd. Procédé de synthèse du rameltéon et ses intermédiaires
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
KR20100058660A (ko) * 2007-10-23 2010-06-03 테바 파마슈티컬 인더스트리즈 리미티드 다사티닙 다형체 및 이의 제조 방법
WO2009056993A2 (fr) * 2007-11-01 2009-05-07 Teva Pharmaceutical Industries Ltd. Procédé de synthèse de rameltéon et intermédiaires de ce dernier
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine
WO2009151494A1 (fr) * 2008-03-06 2009-12-17 Teva Pharmaceutical Industries Ltd. Procédés de préparation de la o-desméthylvenlafaxine, exempte de ses impuretés dimères
WO2009158343A1 (fr) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Synthèse enzymatique stéréosélective de l’ester (s) ou (r)-isobutylglutarique
US20100152468A1 (en) * 2008-10-16 2010-06-17 Teva Pharmaceutical Industries Ltd. Process for the synthesis of ramelteon and its intermediates
CA2795023A1 (fr) * 2010-03-29 2011-10-06 Pliva Hrvatska D.O.O. Formes cristallines du fumarate de o-desmethylvenlafaxine
WO2012034065A1 (fr) 2010-09-09 2012-03-15 Teva Pharmaceutical Industries Ltd. Intermédiaires d'aliskirène et procédé destiné à analyser la pureté de l'aliskirène
CN102766104A (zh) * 2012-08-20 2012-11-07 三金集团湖南三金制药有限责任公司 一种治疗双向情感障碍及癫痫病药物拉莫三嗪的合成方法
US10189859B2 (en) 2013-12-21 2019-01-29 Nektar Therapeutics Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
CN110467560B (zh) 2018-05-09 2025-11-25 深圳微芯生物科技股份有限公司 一种苯基氨基丙酸钠衍生物、其制备方法和应用
KR102270026B1 (ko) * 2020-01-31 2021-06-28 현대약품 주식회사 (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
CN113156009B (zh) * 2021-04-20 2023-12-22 三金集团湖南三金制药有限责任公司 高效液相色谱分析拉莫三嗪的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68380B (fr) 1979-06-01 1981-12-28 Wellcome Found
EP0021120B1 (fr) 1979-06-01 1983-04-06 The Wellcome Foundation Limited Dérivés de la diamino-3,5 triazine-1,2,4, procédé pour la préparation de tels composés et compositions pharmaceutiques les contenant
GB8613183D0 (en) 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
WO1996020934A1 (fr) * 1994-12-30 1996-07-11 The Wellcome Foundation Limited Procede de preparation de lamotrigine
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation

Also Published As

Publication number Publication date
DE69901656D1 (de) 2002-07-11
US6333198B1 (en) 2001-12-25
HRP990074A2 (en) 2000-10-31
EA000666B1 (ru) 2000-02-28
ID22957A (id) 1999-12-23
NO991151D0 (no) 1999-03-10
CN1306210A (zh) 2001-08-01
PL331870A1 (en) 1999-12-20
KR100322354B1 (ko) 2002-02-07
TR199900520A2 (en) 2000-01-21
EP0963980B1 (fr) 2002-06-05
PT963980E (pt) 2002-10-31
ATE218552T1 (de) 2002-06-15
ES2178342T3 (es) 2002-12-16
EP1170588A1 (fr) 2002-01-09
SI0963980T1 (en) 2002-12-31
HUP9900592A2 (hu) 2000-04-28
PE20000332A1 (es) 2000-04-10
CN1238454A (zh) 1999-12-15
HUP9900592A3 (en) 2002-04-29
TR199900520A3 (tr) 2000-01-21
AU2031999A (en) 2000-01-06
EA199900159A1 (ru) 1999-12-29
KR20000005611A (ko) 2000-01-25
DE69901656T2 (de) 2003-01-30
JP2989189B1 (ja) 1999-12-13
BR9900984A (pt) 2000-05-02
EP0963980A3 (fr) 2000-05-31
EP0963980A2 (fr) 1999-12-15
GB9812413D0 (en) 1998-08-05
ZA991951B (en) 1999-08-16
UY25946A1 (es) 2000-12-29
JP2000009714A (ja) 2000-01-14
AP0102286A0 (en) 2000-09-10
CA2265194C (fr) 2000-10-10
YU12399A (sh) 2002-08-12
NO20032753D0 (no) 2003-06-17
AP2001002286A0 (en) 2001-12-31
HU9900592D0 (en) 1999-04-28
NZ334590A (en) 2000-07-28
NO20032753L (no) 1999-12-13
NO991151L (no) 1999-12-13
AP9901481A0 (en) 1999-03-31
DK0963980T3 (da) 2002-09-16
AR014074A1 (es) 2001-01-31
SG85628A1 (en) 2002-01-15

Similar Documents

Publication Publication Date Title
MA24777A1 (fr) Compose et son utilisation
NO20001830D0 (no) Ny kombinasjon
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
DE59808130D1 (de) Selbstklebeband
NO20005503D0 (no) Ny anvendelse
NO2010022I1 (no) Denosumab
DE69930846D1 (de) Mehrkonfiguration-rückwand
BR9711191A (pt) Composto e uso do mesmo
NO20002659L (no) Trombinreseptorantagonister
DE59908239D1 (de) Klebestreifen
FI974130L (fi) Puskurinhallinta
DE69823692D1 (de) Magnetband
ID16990A (id) Penghambat-penghambat trombin
DE69933597D1 (de) Hebezeug
DE69824117D1 (de) Kassettenladevorrichtung
FR2767634B1 (fr) Godet desileur
FR2759536B1 (fr) Godet desileur
IT1291997B1 (it) Preparati-farmaceutici-topici-contenenti nimesulide
ATA4098A (de) Tragkonstruktion
KR970051823U (ko) 로면 테이프
FI980691A0 (fi) Xylitoltillsats i roektobak
SE9703483D0 (sv) New use
KR970056660U (ko) T자형 칫솔
FI2928U1 (fi) Nostolaite
SE9802610D0 (sv) New use